Kelkar P S, Butterfield J H, Teaford H G
Division of Allergy and Immunology, Mayo Clinic, Rochester, MN 55905, USA.
J Rheumatol. 2001 Nov;28(11):2553-4.
Cyclooxygenase-2 (COX-2) inhibitors celecoxib and rofecoxib have generally been well tolerated. It has been unclear if specific COX-2 inhibitors would cross react with acetylsalicylic acid and typical nonsteroidal antiinflammatory drugs to cause urticaria or angioedema. There are no reports in the literature of hives or angioedema resulting from their use. We describe 3 patients who developed urticaria and/or angioedema from COX-2 inhibitors. With the increasing use of COX-2 inhibitors, one needs to be aware of these side effects and of possible cross reactivity between celecoxib and rofecoxib.
环氧化酶-2(COX-2)抑制剂塞来昔布和罗非昔布总体耐受性良好。目前尚不清楚特定的COX-2抑制剂是否会与乙酰水杨酸及典型的非甾体抗炎药发生交叉反应,从而引发荨麻疹或血管性水肿。文献中尚无因使用这些药物导致荨麻疹或血管性水肿的报道。我们描述了3例因COX-2抑制剂出现荨麻疹和/或血管性水肿的患者。随着COX-2抑制剂使用的增加,人们需要了解这些副作用以及塞来昔布和罗非昔布之间可能存在的交叉反应。